Key Financial’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Other funds holding KRYS
Key Financial's KRYS Position: Q3 2026 in Review
Key Financial held its Krystal Biotech (KRYS) position steady in Q3 2026 at 151 shares worth $50.2K. The position accounts for 0.01% of the portfolio, ranked #528.
Key Financial first reported a position in KRYS in Q2 2024 and has held it in 10 quarters since. The position peaked at $56.1K in Q2 2026. 353 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.
- Key Financial held 151 shares of Krystal Biotech worth $50.2K as of Q3 2026.
- Key Financial left its Krystal Biotech share count unchanged in Q3 2026.
- Krystal Biotech made up 0.01% of Key Financial's portfolio in Q3 2026, its #528 holding.
- Key Financial first reported a position in Krystal Biotech in Q2 2024 and has held it in 10 quarters since.
- Key Financial's Krystal Biotech position peaked at $56.1K in Q2 2026.
- 353 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.
Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.